Form EFFECT Coya Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 29, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coya plans open-label extension of ALS trial, delays FTD study
- BNB Price Prediction: BNB Near $720 After Binance’s Stock-Token Additions as Remittix Brings a New Ecosystem Bet
- Cardano Price Prediction: ADA Near $0.224 and a Busy Transaction Epoch Meet Remittix’s November Launch Story
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share